Eric Ouellet

Title: Eric Ouellet: Innovator in Transfection Technology

Introduction

Eric Ouellet is a notable inventor based in New Westminster, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of transfection reagents. His work focuses on enhancing the delivery of nucleic acids into resistant cell types, which is crucial for various therapeutic applications.

Latest Patents

Eric Ouellet holds a patent for "Compositions for transfecting resistant cell types." This innovative transfection reagent composition comprises 30-60 MOL. % of a cationic lipid, or a pharmaceutical acceptable salt thereof; 10-60 MOL % of a structural lipid; 10-20 MOL % of a triglyceride; and 0.1 to about 10 MOL. % of a stabilizing agent. The transfection agent is effective in transfecting cells, particularly neurons, with siRNA, mRNA, and plasmid nucleic acid, while maintaining the viability of the cells as well as the activity of the delivered nucleic acid.

Career Highlights

Eric Ouellet is currently associated with Precision Nanosystems Inc., where he continues to advance his research and development efforts. His work has positioned him as a key player in the biotechnology sector, contributing to innovative solutions that address complex challenges in gene delivery.

Collaborations

Throughout his career, Eric has collaborated with talented individuals such as Anitha Thomas and Rebecca Anne Grace De Souza. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field.

Conclusion

Eric Ouellet's contributions to transfection technology exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Precision Nanosystems Inc. highlight his commitment to advancing scientific knowledge and improving therapeutic outcomes.